Envoy Medical draws remaining $5M from GAT Funding; issues warrant for 750K shares at $1.48

Envoy Medical, Inc.

Drew $5M remaining principal under March 2025 note from GAT Funding, controlled by board member Glen Taylor.
Issued warrant for 750,000 shares of Class A common at $1.48/share closing price, exercisable for two years.
Warrant issued as commitment fee for draw; transaction is a related-party financing.

item 1.01item 2.03item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.